Impact of genomic background and developmental state on signaling pathways and response to therapy in glioblastoma patient-derived cells.
Berezovsky A, Nuga O, Datta I, Bergman K, Sabedot T, Gurdziel K, Irtenkauf S, Hasselbach L, Meng Y, Mueller C, Petricoin EF, Brown S, Purandare N, Aras S, Mikkelsen T, Poisson L, Noushmehr H, Ruden D, deCarvalho AC.
Berezovsky A, et al.
bioRxiv [Preprint]. 2024 Sep 23:2024.03.14.585115. doi: 10.1101/2024.03.14.585115.
bioRxiv. 2024.
PMID: 39386580
Free PMC article.
Preprint.